SCHEMBL2479509

SCHEMBL2479509

Cc1ccc(Cc2nc(Nc3ccc(-n4ccnc4C)cc3)nc3c2CN(CC(O)C(CO)N2CCc4nc(Nc5ccc(-n6ccnc6C)cc5)nc(CCc5cccc(F)c5)c4C2)CC3)cc1

nearest known ligand 0.31

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CDK9 P50750 4/20 0.31
CCNT1 O60563 3/20 0.31
ROCK2 O75116 1/20 0.31
TRPV1 Q8NER1 1/20 0.30
CARM1 Q86X55 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2479506 0.88 ROCK2 (0.35) ROCK2
SCHEMBL2479140 0.83 ROCK2 (0.38) ROCK2
SCHEMBL2451552 0.79 ROCK2 (0.43) ROCK2TRPV1
SCHEMBL2480448 0.79 ROCK2 (0.39) ROCK2
SCHEMBL2477751 0.78 MAPT (0.35) ROCK2
SCHEMBL2444206 0.78 CREBBP (0.40) ROCK2
SCHEMBL2447040 0.75 NTRK1 (0.37) ROCK2
SCHEMBL2480700 0.75 ROCK2 (0.38) ROCK2
SCHEMBL8905533 0.74 MAPT (0.44) CDK9CCNT1ROCK2TRPV1
SCHEMBL2446341 0.74 ROCK2 (0.40) ROCK2TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2367826-A1 MODULATORS OF AMYLOID BETA. AstraZeneca AB (SE) 2011-09-28 EP disclosed
WO-2010053438-A1 MODULATORS OF AMYLOID BETA. ASTRAZENECA AB (SE) 2010-05-14 WO disclosed